Found: 31
Select item for more details and to access through your institution.
Instent CTO—What Is the Best Treatment Strategy?
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 393, doi. 10.1007/s10557-024-07556-2
- By:
- Publication type:
- Article
Poking and Prodding So They Take Their Pills.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 395, doi. 10.1007/s10557-023-07487-4
- By:
- Publication type:
- Article
When Less is More: Drug-Coated Balloons Threaten a Paradigm Revolution.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 397, doi. 10.1007/s10557-023-07542-0
- By:
- Publication type:
- Article
Open Issues in the Management of Otcagerian Patients with Atrial Fibrillation and Chronic Kidney Disease: Are we Ready for Left Atrial Appendage Occlusion (LAAO) as First-Line Therapy for Thromboembolic Risk Prevention?
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 401, doi. 10.1007/s10557-024-07554-4
- By:
- Publication type:
- Article
Impairment of Vascular Homeostasis in Acute Heart Failure: Enter the Monocyte?
- Published in:
- 2024
- By:
- Publication type:
- Abstract
Beyond Hepatoprotection—The Cardioprotective Effects of Bicyclol in Diabetes.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 411, doi. 10.1007/s10557-023-07536-y
- By:
- Publication type:
- Article
C/EBP Homologous Protein: A Potential Therapeutic Target for Atherosclerosis Treatment?
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 415, doi. 10.1007/s10557-022-07424-x
- By:
- Publication type:
- Article
Possible Cardioprotective Effects of Lactate Infusion After Cardiac Arrest or Prolonged Myocardial Ischemia.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 417, doi. 10.1007/s10557-023-07524-2
- By:
- Publication type:
- Article
IL-33 in Atherosclerosis: An Insufficiently Explored and Controversial Research Area.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 419, doi. 10.1007/s10557-024-07553-5
- By:
- Publication type:
- Article
The Potential Cardiovascular Benefits of COVID-19 Vaccination: Lessons from Influenza and Emerging Evidence.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 421, doi. 10.1007/s10557-023-07485-6
- By:
- Publication type:
- Article
MicroRNA-92a in Cardiovascular Disease: An Insufficiently Explored and Controversial Research Area.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 423, doi. 10.1007/s10557-023-07533-1
- By:
- Publication type:
- Article
Promising Drug Fondaparinux for the Treatment of COVID-19: an In Silico Analysis of Low Molecular Weight Heparin, Direct Oral Anticoagulant, and Antiplatelet Drug Interactions with Host Protease Furin.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 425, doi. 10.1007/s10557-022-07406-z
- By:
- Publication type:
- Article
Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 433, doi. 10.1007/s10557-022-07411-2
- By:
- Publication type:
- Article
Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y<sub>12</sub> Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 447, doi. 10.1007/s10557-022-07392-2
- By:
- Publication type:
- Article
Comparative Muscle Tolerability of Different Types and Intensities of Statins: A Network Meta-Analysis of Double-Blind Randomized Controlled Trials.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 459, doi. 10.1007/s10557-022-07405-0
- By:
- Publication type:
- Article
Left Bundle Branch Area Pacing versus Biventricular Pacing for Cardiac Resynchronization Therapy on Morbidity and Mortality.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 471, doi. 10.1007/s10557-022-07410-3
- By:
- Publication type:
- Article
Left Ventricular Thrombus Management After Acute Myocardial Infarction in Clinical Practice: Results from LEVITATION Survey and Narrative Review.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 483, doi. 10.1007/s10557-022-07417-w
- By:
- Publication type:
- Article
Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 493, doi. 10.1007/s10557-022-07413-0
- By:
- Publication type:
- Article
Sacubitril/valsartan improves all-cause mortality in heart failure patients with reduced ejection fraction and chronic kidney disease.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 505, doi. 10.1007/s10557-022-07421-0
- By:
- Publication type:
- Article
The Association of Proton Pump Inhibitors and QT Interval Prolongation in Critically Ill Patients.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 517, doi. 10.1007/s10557-023-07425-4
- By:
- Publication type:
- Article
Mitogen-Activated Protein Kinases Mediate Adventitial Fibroblast Activation and Neointima Formation via GATA4/Cyclin D1 Axis.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 527, doi. 10.1007/s10557-023-07428-1
- By:
- Publication type:
- Article
Vaccine Targeting Alpha 1D-Adrenergic Receptor Improved Metabolic Syndrome in Mice.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 539, doi. 10.1007/s10557-022-07418-9
- By:
- Publication type:
- Article
Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 555, doi. 10.1007/s10557-023-07426-3
- By:
- Publication type:
- Article
IL-33 Suppresses the Progression of Atherosclerosis via the ERK1/2-IRF1-VCAM-1 Pathway.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 569, doi. 10.1007/s10557-023-07523-3
- By:
- Publication type:
- Article
PrevAleNce and Associated factors of inappropriaTe dosing of direct Oral anticoaguLants In pAtients with Atrial Fibrillation: the ANATOLIA-AF Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 581, doi. 10.1007/s10557-022-07409-w
- By:
- Publication type:
- Article
Correction to: Prevalence and Associated Factors of Inappropriate Dosing of Direct Oral Anticoagulants In Patients With Atrial Fibrillation: The ANATOLIA-AF Study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
The Cost of Breaking Even: a Perspective on the Net Clinical Impact of Adding Aspirin to Antithrombotic Therapies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 605, doi. 10.1007/s10557-022-07367-3
- By:
- Publication type:
- Article
Influence of Genetic and Epigenetic Factors of P2Y<sub>12</sub> Receptor on the Safety and Efficacy of Antiplatelet Drugs.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 621, doi. 10.1007/s10557-022-07370-8
- By:
- Publication type:
- Article
Direct Oral Anticoagulants: Navigating Through Clinical Challenges.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 637, doi. 10.1007/s10557-023-07499-0
- By:
- Publication type:
- Article
Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 651, doi. 10.1007/s10557-022-07420-1
- By:
- Publication type:
- Article
Correction to: Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis‑Related Pulmonary Hypertension.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice